Birchview Capital as of March 31, 2016
Portfolio Holdings for Birchview Capital
Birchview Capital holds 40 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 55.6 | $78M | 779k | 100.09 | |
| Accelr8 Technology | 22.3 | $31M | 2.2M | 14.37 | |
| Vermillion | 2.9 | $4.0M | 2.7M | 1.47 | |
| Metabolix | 2.8 | $3.9M | 2.3M | 1.71 | |
| EQT Corporation (EQT) | 2.0 | $2.8M | 42k | 67.26 | |
| Biolase Technology | 1.2 | $1.7M | 1.3M | 1.31 | |
| Contrafect | 1.1 | $1.6M | 475k | 3.40 | |
| Masimo Corporation (MASI) | 1.1 | $1.5M | 37k | 41.83 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.0 | $1.4M | 77k | 18.15 | |
| Hansen Medical | 1.0 | $1.4M | 528k | 2.61 | |
| Neurocrine Biosciences (NBIX) | 0.7 | $997k | 25k | 39.56 | |
| Medivation | 0.6 | $863k | 19k | 46.00 | |
| Merck & Co (MRK) | 0.6 | $794k | 15k | 52.93 | |
| Encana Corp | 0.6 | $806k | 132k | 6.09 | |
| Oncomed Pharmaceuticals | 0.5 | $715k | 71k | 10.11 | |
| Quidel Corporation | 0.5 | $673k | 39k | 17.27 | |
| Oxford Immunotec Global | 0.4 | $558k | 56k | 9.91 | |
| Accuray Incorporated (ARAY) | 0.4 | $551k | 95k | 5.78 | |
| Quotient | 0.4 | $512k | 58k | 8.80 | |
| Wright Medical | 0.4 | $498k | 30k | 16.60 | |
| Cabot Oil & Gas Corporation (CTRA) | 0.3 | $477k | 21k | 22.71 | |
| Sientra | 0.3 | $433k | 63k | 6.84 | |
| Pioneer Natural Resources | 0.3 | $422k | 3.0k | 140.67 | |
| NxStage Medical | 0.3 | $423k | 28k | 15.00 | |
| Corcept Therapeutics Incorporated (CORT) | 0.3 | $374k | 80k | 4.68 | |
| Merrimack Pharmaceuticals In | 0.3 | $368k | 44k | 8.36 | |
| Advaxis | 0.2 | $321k | 36k | 9.02 | |
| Kura Oncology (KURA) | 0.2 | $320k | 79k | 4.04 | |
| Celgene Corp right 12/31/2011 | 0.2 | $312k | 238k | 1.31 | |
| Tesaro | 0.2 | $306k | 7.0k | 44.03 | |
| Genocea Biosciences | 0.2 | $302k | 39k | 7.74 | |
| Biogen Idec (BIIB) | 0.2 | $260k | 1.0k | 260.00 | |
| Pacific Biosciences of California (PACB) | 0.2 | $230k | 27k | 8.52 | |
| Transition Therapeutics | 0.1 | $187k | 146k | 1.28 | |
| Raptor Pharmaceutical | 0.1 | $184k | 40k | 4.60 | |
| Intercept Pharmaceuticals In | 0.1 | $167k | 1.3k | 128.46 | |
| Xencor (XNCR) | 0.1 | $165k | 12k | 13.41 | |
| Roka Bioscience | 0.1 | $174k | 252k | 0.69 | |
| Cerus Corporation (CERS) | 0.1 | $157k | 27k | 5.92 | |
| Coherus Biosciences (CHRS) | 0.1 | $159k | 7.5k | 21.20 |